1. Effect of calcitriol treatment on arterial stiffness in people with type 2 diabetes and stage 3 chronic kidney disease. Issue 1 (25th August 2022) Authors: Karalliedde, Janaka; Fountoulakis, Nikolaos; Corcillo, Antonella; Maltese, Giuseppe; Flaquer, Maria; Stathi, Dimitra; Mangelis, Anastasios; Panagiotou, Angeliki; Ayis, Salma; Thomas, Stephen; Gnudi, Luigi Journal: British journal of clinical pharmacology Issue: Volume 89:Issue 1(2023) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Exploring macrophage cell therapy on Diabetic Kidney Disease. Issue 2 (8th November 2018) Authors: Guiteras, Roser; Sola, Anna; Flaquer, Maria; Manonelles, Anna; Hotter, Georgina; Cruzado, Josep M. Journal: Journal of cellular and molecular medicine Issue: Volume 23:Issue 2(2019) Page Start: 841 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FP505PLASMA DEPHOSPHORYLATED-UNCARBOXYLATED MATRIX GIa PROTEIN, A POTENT INHIBITOR OF VASCULAR CALCIFICATION, IS ASSOCIATED WITH 1, 25 ACTIVE VITAMIN D3 LEVELS AND MARKERS OF BONE TURNOVER IN PATIENTS WITH DIABETIC KIDNEY DISEASE. (13th June 2019) Authors: Panagiotou, Angeliki; Fountoulakis, Nikolaos; Flaquer, Maria; Gnudi, Luigi; Karalliedde, Janaka Journal: Nephrology dialysis transplantation Issue: Volume 34(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗